Evidence for a Tumor Suppressor Gene on Chromosome 19q Associated with Human Astrocytomas, Oligodendrogliomas, and Mixed Gliomas

作者: A. Von Deimling , D. N. Louis , D. N. Louis , B. R. Seizinger , I. Petersen

DOI:

关键词:

摘要: Abstract Previous studies have shown frequent allelic losses of chromosomes 9p, 10, 17p, and 22q in glial tumors. Other researchers briefly reported that tumors may also show chromosome 19, suggesting a putative tumor suppressor gene locus on this (D. T. Ransom et al. , Proc. Am. Assoc. Cancer Res., 32: 302, 1991). To evaluate whether loss 19 alleles is common different types grades, we performed Southern blot restriction fragment length polymorphism analysis for multiple loci 122 gliomas from 116 patients. Twenty-nine had constitutional heterozygosity 19q, four partial deletions 19q. Allelic 19q were restricted to grade III anaplastic astrocytomas (4/9) IV glioblastomas (11/46), II oligodendrogliomas (2/5) (2/2), (5/8) (5/7) mixed oligoastrocytomas. These data demonstrate genetic similarities between astrocytomas, oligodendrogliomas, indicate the presence

参考文章(14)
M. Nordenskjold, E. Carlbom, V. P. Collins, W. K. Cavenee, C. D. James, J. He, J. He, Chromosome 9 deletion mapping reveals interferon alpha and interferon beta-1 gene deletions in human glial tumors. Cancer Research. ,vol. 51, pp. 1684- 1688 ,(1991)
Darell D. Bigner, Dennis E. Bullard, Joachim Mark, Peter C. Burger, Lawrence H. Muhlbaier, Sandra H. Bigner, M. Stephen Mahaley, Specific Chromosomal Abnormalities in Malignant Human Gliomas Cancer Research. ,vol. 48, pp. 405- 411 ,(1988)
Richard M. Cawthon, Carolyn A. Pedone, Douglas Brockmeyer, Dan Fults, Micam W. Tullous, p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Research. ,vol. 52, pp. 674- 679 ,(1992)
Jon Glass, Fred H. Hochberg, Michael L. Gruber, David N. Louis, David Smith, Barbara Rattner, The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy Journal of Neurosurgery. ,vol. 76, pp. 741- 745 ,(1992) , 10.3171/JNS.1992.76.5.0741
Alfred G Knudson, Genetics and the Etiology of Childhood Cancer Pediatric Research. ,vol. 10, pp. 513- 517 ,(1976) , 10.1203/00006450-197605000-00001
David Sidransky, Tom Mikkelsen, Karl Schwechheimer, Mark L. Rosenblum, Web Cavanee, Bert Vogelstein, Clonal expansion of p53 mutant cells is associated with brain tumour progression Nature. ,vol. 355, pp. 846- 847 ,(1992) , 10.1038/355846A0
R. B. Richter, Pathology of Tumors of the Nervous System. JAMA Neurology. ,vol. 11, pp. 336- 337 ,(1964) , 10.1001/ARCHNEUR.1964.00460210114015
Robert B. Jenkins, David W. Kimmel, Cheryl A. Moertel, Cloann G. Schultz, Bernd W. Scheithauer, Patrick J. Kelly, Gordon W. Dewald, A cytogenetic study of 53 human gliomas. Cancer Genetics and Cytogenetics. ,vol. 39, pp. 253- 279 ,(1989) , 10.1016/0165-4608(89)90192-1
Andreas von Deimling, Paul Kleihues, Hiroko Ohgaki, Robert H. Eibl, Otmar D. Wiestler, David N. Louis, Richard Y. Chung, Bernd R. Seizinger, Klaus von Ammon, Iver Petersen, Iver Petersen, p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Research. ,vol. 52, pp. 2987- 2990 ,(1992)